Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Bioscience
Clean Technology
Information Technology
Medical Device

Cornovus Pharmaceuticals

About: Cornovus Pharmaceuticals has identified a new target and class of agents to treat cardiac failure. The technology, which has been proven in mouse models, delays the onset of heart failure after a heart attack or injury.

CI Representative:
Daniel Wagner
Managing Director, Investments

[photo]